Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Non-Current Deffered Revenue (2021 - 2023)

OneMedNet has reported Non-Current Deffered Revenue over the past 3 years, most recently at $4.0 million for Q3 2023.

  • Quarterly Non-Current Deffered Revenue changed 0.0% to $4.0 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Sep 2023, changed 0.0% year-over-year, with the annual reading at $4.0 million for FY2022, 0.0% changed from the prior year.
  • Non-Current Deffered Revenue was $4.0 million for Q3 2023 at OneMedNet, roughly flat from $4.0 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $4.0 million in Q4 2021 and troughed at $4.0 million in Q4 2021.
  • The 3-year median for Non-Current Deffered Revenue is $4.0 million (2021), against an average of $4.0 million.
  • The largest YoY upside for Non-Current Deffered Revenue was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $4.0 million in 2021, then changed by 0.0% to $4.0 million in 2022, then changed by 0.0% to $4.0 million in 2023.
  • Per Business Quant, the three most recent readings for ONMD's Non-Current Deffered Revenue are $4.0 million (Q3 2023), $4.0 million (Q2 2023), and $4.0 million (Q1 2023).